Original article
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice
Uso real de apremilast en pacientes con artritis psoriásica sin tratamiento biológico. Datos de la práctica clínica española
Jordi Gratacós-Masmitjaa, Emma Beltrán Catalánb, José Luis Álvarez Vegac, Ana Urruticoechea-Aranad, Concepción Fitoe, Francisco Maceirasf, Joaquín María Belzunegui Otanog, Julia Fernández Melónh, Eugenio Chamizo Carmonai, Miguel Ángel Abad Hernándezj, Inmaculada Ros Vilamajók, Sonia Castro Oreirol, Eva Pascual Alfonsom, Juan Carlos Torre Alonson,
, on behalf of the PREVAIL team 1
Corresponding author
a Rheumatology Service, University Hospital Parc Taulí (I3PT), Medicine Department UAB, Barcelona, Spain
b Hospital del Mar, Barcelona, Spain
c Hospital Perpetuo Socorro, Badajoz, Spain
d Hospital Can Misses, Ibiza, Spain
e Complejo Hospitalario de Navarra, Pamplona, Spain
f Complejo Hospitalario Universitario de Vigo, Vigo, Spain
g Hospital Universitario Donostia, Donostia, Spain
h Hospital Universitario Son Espases, Palma de Mallorca, Spain
i Hospital de Mérida, Mérida, Spain
j Hospital Virgen del Puerto, Plasencia, Spain
k Hospital Son Llàtzer, Palma de Mallorca, Spain
l Hospital Joan XXIII, Tarragona, Spain
m Amgen, Spain
n Hospital Monte Naranco, Oviedo, Spain
Ver másRead
2126
Timeswas read the article
348
Total PDF
1778
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 September | 270 | 34 | 304 |
| 2024 August | 432 | 70 | 502 |
| 2024 July | 374 | 72 | 446 |
| 2024 June | 409 | 99 | 508 |
| 2024 May | 278 | 65 | 343 |
| 2024 April | 8 | 3 | 11 |
| 2024 February | 7 | 5 | 12 |
